FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2917305441> ?p ?o ?g. }

• W2917305441 endingPage "363" @default.
• W2917305441 startingPage "363" @default.
• W2917305441 abstract "<h3>Importance</h3> Cognitive behavioral therapy (CBT), the best-studied treatment for body dysmorphic disorder (BDD), has to date not been compared with therapist-delivered supportive psychotherapy, the most commonly received psychosocial treatment for BDD. <h3>Objective</h3> To determine whether CBT for BDD (CBT-BDD) is superior to supportive psychotherapy in reducing BDD symptom severity and associated BDD-related insight, depressive symptoms, functional impairment, and quality of life, and whether these effects are durable. <h3>Design, Setting, and Participants</h3> This randomized clinical trial conducted at Massachusetts General Hospital and Rhode Island Hospital recruited adults with BDD between October 24, 2011, and July 7, 2016. Participants (n = 120) were randomized to the CBT-BDD arm (n = 61) or the supportive psychotherapy arm (n = 59). Weekly treatments were administered at either hospital for 24 weeks, followed by 3- and 6-month follow-up assessments. Measures were administered by blinded independent raters. Intention-to-treat statistical analyses were performed from February 9, 2017, to September 22, 2018. <h3>Interventions</h3> Cognitive behavioral therapy for BDD, a modular skills–based treatment, addresses the unique symptoms of the disorder. Supportive psychotherapy is a nondirective therapy that emphasizes the therapeutic relationship and self-esteem; supportive psychotherapy was enhanced with BDD-specific psychoeducation and treatment rationale. <h3>Main Outcomes and Measures</h3> The primary outcome was BDD symptom severity measured by the change in score on the Yale-Brown Obsessive-Compulsive Scale Modified for BDD from baseline to end of treatment. Secondary outcomes were the associated symptoms and these were assessed using the Brown Assessment of Beliefs Scale, Beck Depression Inventory–Second Edition, Sheehan Disability Scale, and Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form. <h3>Results</h3> Of the 120 participants, 92 (76.7%) were women, with a mean (SD) age of 34.0 (13.1) years. The difference in effectiveness between CBT-BDD and supportive psychotherapy was site specific: at 1 site, no difference was detected (estimated mean [SE] slopes, –18.6 [1.9] vs –16.7 [1.9];<i>P</i> = .48;<i>d</i>growth-modeling analysis change, –0.25), whereas at the other site, CBT-BDD led to greater reductions in BDD symptom severity, compared with supportive psychotherapy (estimated mean [SE] slopes, –18.6 [2.2] vs –7.6 [2.0];<i>P</i> < .001;<i>d</i>growth-modeling analysis change, –1.36). No posttreatment symptom changes were observed throughout the 6 -months of follow-up (all slope<i>P</i> ≥ .10). <h3>Conclusions and Relevance</h3> Body dysmorphic disorder severity and associated symptoms appeared to improve with both CBT-BDD and supportive psychotherapy, although CBT-BDD was associated with more consistent improvement in symptom severity and quality of life. <h3>Trial Registration</h3> ClinicalTrials.gov identifier:NCT01453439" @default.
• W2917305441 created "2019-03-02" @default.
• W2917305441 creator A5023304393 @default.
• W2917305441 creator A5034427132 @default.
• W2917305441 creator A5044481779 @default.
• W2917305441 creator A5052559293 @default.
• W2917305441 creator A5060482398 @default.
• W2917305441 creator A5068093329 @default.
• W2917305441 creator A5073706036 @default.
• W2917305441 creator A5087626596 @default.
• W2917305441 date "2019-04-01" @default.
• W2917305441 modified "2023-09-26" @default.
• W2917305441 title "Efficacy and Posttreatment Effects of Therapist-Delivered Cognitive Behavioral Therapy vs Supportive Psychotherapy for Adults With Body Dysmorphic Disorder" @default.
• W2917305441 cites W1766812542 @default.
• W2917305441 cites W1816775564 @default.
• W2917305441 cites W1966470720 @default.
• W2917305441 cites W2013184033 @default.
• W2917305441 cites W2017152382 @default.
• W2917305441 cites W2019898273 @default.
• W2917305441 cites W2027411701 @default.
• W2917305441 cites W2065379414 @default.
• W2917305441 cites W2066807621 @default.
• W2917305441 cites W2069333082 @default.
• W2917305441 cites W2079144441 @default.
• W2917305441 cites W2080402734 @default.
• W2917305441 cites W2082564226 @default.
• W2917305441 cites W2089376243 @default.
• W2917305441 cites W2089811587 @default.
• W2917305441 cites W2108682394 @default.
• W2917305441 cites W2119693055 @default.
• W2917305441 cites W2127575423 @default.
• W2917305441 cites W2136764176 @default.
• W2917305441 cites W2137677848 @default.
• W2917305441 cites W2147106787 @default.
• W2917305441 cites W2147520350 @default.
• W2917305441 cites W2151220043 @default.
• W2917305441 cites W2161156593 @default.
• W2917305441 cites W2162696431 @default.
• W2917305441 cites W2166071618 @default.
• W2917305441 cites W2166084011 @default.
• W2917305441 cites W2167265477 @default.
• W2917305441 cites W2253482453 @default.
• W2917305441 cites W2321297318 @default.
• W2917305441 cites W2428515139 @default.
• W2917305441 cites W2794770411 @default.
• W2917305441 cites W4230090792 @default.
• W2917305441 cites W4247665917 @default.
• W2917305441 cites W568093297 @default.
• W2917305441 doi "https://doi.org/10.1001/jamapsychiatry.2018.4156" @default.
• W2917305441 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6450292" @default.
• W2917305441 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30785624" @default.
• W2917305441 hasPublicationYear "2019" @default.
• W2917305441 type Work @default.
• W2917305441 sameAs 2917305441 @default.
• W2917305441 citedByCount "56" @default.
• W2917305441 countsByYear W29173054412019 @default.
• W2917305441 countsByYear W29173054412020 @default.
• W2917305441 countsByYear W29173054412021 @default.
• W2917305441 countsByYear W29173054412022 @default.
• W2917305441 countsByYear W29173054412023 @default.
• W2917305441 crossrefType "journal-article" @default.
• W2917305441 hasAuthorship W2917305441A5023304393 @default.
• W2917305441 hasAuthorship W2917305441A5034427132 @default.
• W2917305441 hasAuthorship W2917305441A5044481779 @default.
• W2917305441 hasAuthorship W2917305441A5052559293 @default.
• W2917305441 hasAuthorship W2917305441A5060482398 @default.
• W2917305441 hasAuthorship W2917305441A5068093329 @default.
• W2917305441 hasAuthorship W2917305441A5073706036 @default.
• W2917305441 hasAuthorship W2917305441A5087626596 @default.
• W2917305441 hasBestOaLocation W29173054411 @default.
• W2917305441 hasConcept C118552586 @default.
• W2917305441 hasConcept C126322002 @default.
• W2917305441 hasConcept C150966472 @default.
• W2917305441 hasConcept C15744967 @default.
• W2917305441 hasConcept C168563851 @default.
• W2917305441 hasConcept C169900460 @default.
• W2917305441 hasConcept C203987217 @default.
• W2917305441 hasConcept C27415008 @default.
• W2917305441 hasConcept C2778455770 @default.
• W2917305441 hasConcept C2779477915 @default.
• W2917305441 hasConcept C2779951463 @default.
• W2917305441 hasConcept C2780200951 @default.
• W2917305441 hasConcept C2780477327 @default.
• W2917305441 hasConcept C2781265626 @default.
• W2917305441 hasConcept C542102704 @default.
• W2917305441 hasConcept C70410870 @default.
• W2917305441 hasConcept C71924100 @default.
• W2917305441 hasConceptScore W2917305441C118552586 @default.
• W2917305441 hasConceptScore W2917305441C126322002 @default.
• W2917305441 hasConceptScore W2917305441C150966472 @default.
• W2917305441 hasConceptScore W2917305441C15744967 @default.
• W2917305441 hasConceptScore W2917305441C168563851 @default.
• W2917305441 hasConceptScore W2917305441C169900460 @default.
• W2917305441 hasConceptScore W2917305441C203987217 @default.
• W2917305441 hasConceptScore W2917305441C27415008 @default.
• W2917305441 hasConceptScore W2917305441C2778455770 @default.
• W2917305441 hasConceptScore W2917305441C2779477915 @default.
• W2917305441 hasConceptScore W2917305441C2779951463 @default.

• next